Viewing Study NCT04585958


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2026-05-18 @ 2:23 PM
Study NCT ID: NCT04585958
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2020-10-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Malignant Solid Neoplasm View
None Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma View
None Unresectable Malignant Solid Neoplasm View
Keywords: